About

Aims and scope

Clinical Hypertension is the official journal of the Korean Society of Hypertension, and the Korean Society of Pulmonary Hypertension.
Clinical Hypertension is a peer-reviewed, open access journal that aims to publish in all areas of hypertension and vascular disorders. We aim to ensure the widest possible dissemination of research throughout the hypertension community.

The journal focuses on areas within vascular biology, cellular and molecular biology, clinical hypertension, epidemiology, nephrology, endocrinology, neuroscience, pharmacology, genetics, pediatric hypertension and basic science.

Clinical Hypertension is a continuation of the Korean journal, Journal of the Korean Society of Hypertension.

Open access

All articles published by Clinical Hypertension are made freely and permanently accessible online immediately upon publication, without subscription charges or registration barriers. Further information about open access can be found here.

As authors of articles published in Clinical Hypertension you are the copyright holders of your article and have granted to any third party, in advance and in perpetuity, the right to use, reproduce or disseminate your article, according to the BMC license agreement.

For those of you who are US government employees or are prevented from being copyright holders for similar reasons, BMC can accommodate non-standard copyright lines. Please contact us if further information is needed.

Article-processing charges

The publication costs for Clinical Hypertension are covered by Korean Society of Hypertension, so authors do not need to pay an article-processing charge.

Indexing services

All articles published in Clinical Hypertension are included in:

PubMed
PubMed Central
Proquest
Web of Science (ESCI)
SCOPUS
EMBASE
Google Scholar
KoreaMed
Chinese Academy of Sciences -GoOA
DOAJ

The full text of all articles is deposited in digital archives around the world to guarantee long-term digital preservation. You can also access all articles published by BioMed Central on SpringerLink.

All articles published in Clinical Hypertension will be submitted to the National Research Foundation of Korea on the 1st and 15th of every month.

Peer-review policy

Peer-review is the system used to assess the quality of a manuscript before it is published. Independent researchers in the relevant research area assess submitted manuscripts for originality, validity and significance to help editors determine whether the manuscript should be published in their journal. You can read more about the peer-review process here.

Clinical Hypertension operates a single-blind peer-review system, where the reviewers are aware of the names and affiliations of the authors, but the reviewer reports provided to authors are anonymous. The benefit of single-blind peer review is that it is the traditional model of peer review that many reviewers are comfortable with, and it facilitates a dispassionate critique of a manuscript.

Submitted manuscripts will generally be reviewed by two or more experts who will be asked to evaluate whether the manuscript is scientifically sound and coherent, whether it duplicates already published work, and whether or not the manuscript is sufficiently clear for publication. The Editors will reach a decision based on these reports and, where necessary, they will consult with members of the Editorial Board.

Editorial policies

All manuscripts submitted to Clinical Hypertension should adhere to BioMed Central's editorial policies.

Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Citing articles in Clinical Hypertension

Articles in Clinical Hypertension should be cited in the same way as articles in a traditional journal. Because articles are not printed, they do not have page numbers; instead, they are given a unique article number.

Article citations follow this format:

Authors: Title. Clin Hypertens [year], [volume number]:[article number].

e.g. Roberts LD, Hassall DG, Winegar DA, Haselden JN, Nicholls AW, Griffin JL: Increased hepatic oxidative metabolism distinguishes the action of Peroxisome Proliferator-Activated Receptor delta from Peroxisome Proliferator-Activated Receptor gamma in the Ob/Ob mouse. Clin Hypertens 2009, 1:115.

refers to article 115 from Volume 1 of the journal.

Appeals and complaints

Authors who wish to appeal a rejection or make a complaint should follow the procedure outlined in the BMC Editorial Policies .

Benefits of publishing with BMC

High visibility

Clinical Hypertension's open access policy allows maximum visibility of articles published in the journal as they are available to a wide, global audience.

Speed of publication

Clinical Hypertension offers a fast publication schedule whilst maintaining rigorous peer review; all articles must be submitted online, and peer review is managed fully electronically (articles are distributed in PDF form, which is automatically generated from the submitted files). Articles will be published with their final citation after acceptance, in both fully browsable web form, and as a formatted PDF.

Flexibility

Online publication in Clinical Hypertension gives you the opportunity to publish large datasets, large numbers of color illustrations and moving pictures, to display data in a form that can be read directly by other software packages so as to allow readers to manipulate the data for themselves, and to create all relevant links (for example, to PubMed, to sequence and other databases, and to other articles).

Promotion and press coverage

Articles published in Clinical Hypertension are included in article alerts and regular email updates. Some may be highlighted on Clinical Hypertension’s pages and on the BMC homepage.

In addition, articles published in Clinical Hypertension may be promoted by press releases to the general or scientific press. These activities increase the exposure and number of accesses for articles published in Clinical Hypertension. A list of articles recently press-released by journals published by BMC is available here.

Copyright

As an author of an article published in Clinical Hypertension you retain the copyright of your article and you are free to reproduce and disseminate your work (for further details, see the BMC license agreement).

For further information about the advantages of publishing in a journal from BMC, please click here.